This leaflet answers some common questions about Cyclosporin Sandoz. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

Sandoz said its application covers all the indications on the Prolia and Xgeva labels, including osteoporosis in postmenopausal women and in men at increased risk of fractures, treatment-induced ...

Sandoz has claimed the first FDA approvals for ... Amgen sells RANKL inhibitor denosumab as Prolia for osteoporosis in women and men and bone loss caused by other drug treatments, while Xgeva ...